These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 2187814)
1. Calcium is required for binding of Escherichia coli hemolysin (HlyA) to erythrocyte membranes. Boehm DF; Welch RA; Snyder IS Infect Immun; 1990 Jun; 58(6):1951-8. PubMed ID: 2187814 [TBL] [Abstract][Full Text] [Related]
2. Domains of Escherichia coli hemolysin (HlyA) involved in binding of calcium and erythrocyte membranes. Boehm DF; Welch RA; Snyder IS Infect Immun; 1990 Jun; 58(6):1959-64. PubMed ID: 2187815 [TBL] [Abstract][Full Text] [Related]
3. The effects of calcium and other polyvalent cations on channel formation by Escherichia coli alpha-hemolysin in red blood cells and lipid bilayer membranes. Döbereiner A; Schmid A; Ludwig A; Goebel W; Benz R Eur J Biochem; 1996 Sep; 240(2):454-60. PubMed ID: 8841412 [TBL] [Abstract][Full Text] [Related]
4. Effect of Escherichia coli hemolysin on permeability of erythrocyte membranes to calcium. Jorgensen SE; Mulcahy PF; Louis CF Toxicon; 1986; 24(6):559-66. PubMed ID: 3750344 [TBL] [Abstract][Full Text] [Related]
5. Production and characterization of Escherichia coli enterohemolysin and its effects on the structure of erythrocyte membranes. Jürgens D; Ozel M; Takaisi-Kikuni NB Cell Biol Int; 2002; 26(2):175-86. PubMed ID: 11846447 [TBL] [Abstract][Full Text] [Related]
6. Relevance of fatty acid covalently bound to Escherichia coli alpha-hemolysin and membrane microdomains in the oligomerization process. Herlax V; Maté S; Rimoldi O; Bakás L J Biol Chem; 2009 Sep; 284(37):25199-210. PubMed ID: 19596862 [TBL] [Abstract][Full Text] [Related]
13. Calcium accumulation in human and sheep erythrocytes that is induced by Escherichia coli hemolysin. Jorgensen SE; Mulcahy PF; Wu GK; Louis CF Toxicon; 1983; 21(5):717-27. PubMed ID: 6359585 [TBL] [Abstract][Full Text] [Related]
14. Epitopes of Escherichia coli alpha-hemolysin: identification of monoclonal antibodies that prevent hemolysis. Ji GE; O'Hanley P Infect Immun; 1990 Sep; 58(9):3029-35. PubMed ID: 1696938 [TBL] [Abstract][Full Text] [Related]
16. Effects of temperature, time, and toxin concentration on lesion formation by the Escherichia coli hemolysin. Moayeri M; Welch RA Infect Immun; 1994 Oct; 62(10):4124-34. PubMed ID: 7927666 [TBL] [Abstract][Full Text] [Related]
17. Quantitative study of the binding and hemolytic efficiency of Escherichia coli hemolysin. Eberspächer B; Hugo F; Bhakdi S Infect Immun; 1989 Mar; 57(3):983-8. PubMed ID: 2465275 [TBL] [Abstract][Full Text] [Related]
18. Binding of antibodies to functional epitopes on the pore formed by Escherichia coli hemolysin in cells and model membranes. Menestrina G; Ropele M; Dalla Serra M; Pederzolli C; Hugo F; Pellet S; Welch RA Biochim Biophys Acta; 1995 Aug; 1238(1):72-80. PubMed ID: 7654753 [TBL] [Abstract][Full Text] [Related]
19. Pore-formation by Escherichia coli hemolysin (HlyA) and other members of the RTX toxins family. Menestrina G; Moser C; Pellet S; Welch R Toxicology; 1994 Feb; 87(1-3):249-67. PubMed ID: 8160187 [TBL] [Abstract][Full Text] [Related]
20. Characterization of an RTX toxin from enterohemorrhagic Escherichia coli O157:H7. Bauer ME; Welch RA Infect Immun; 1996 Jan; 64(1):167-75. PubMed ID: 8557336 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]